{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "marketState": "POSTPOST", "regularMarketChangePercent": -0.33955985, "regularMarketPrice": 58.7, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.78, "sharesOutstanding": 113642000, "bookValue": 1.99, "fiftyDayAverage": 61.26, "fiftyDayAverageChange": -2.5599976, "fiftyDayAverageChangePercent": -0.04178906, "twoHundredDayAverage": 54.32225, "twoHundredDayAverageChange": 4.3777504, "twoHundredDayAverageChangePercent": 0.080588534, "marketCap": 6670785536, "priceToBook": 29.497488, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "exchange": "TWO", "shortName": "FRMSP", "longName": "Formosa Pharmaceuticals, Inc.", "messageBoardId": "finmb_533359460", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1633568400000, "priceHint": 2, "regularMarketChange": -0.20000076, "regularMarketTime": 1684133980, "regularMarketDayHigh": 59.7, "regularMarketDayRange": "58.4 - 59.7", "regularMarketDayLow": 58.4, "regularMarketVolume": 156893, "regularMarketPreviousClose": 58.9, "bid": 58.3, "ask": 58.7, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 59.0, "averageDailyVolume3Month": 661861, "averageDailyVolume10Day": 369790, "fiftyTwoWeekLowChange": 25.3, "fiftyTwoWeekLowChangePercent": 0.757485, "fiftyTwoWeekRange": "33.4 - 70.0", "fiftyTwoWeekHighChange": -11.299999, "fiftyTwoWeekHighChangePercent": -0.16142856, "fiftyTwoWeekLow": 33.4, "fiftyTwoWeekHigh": 70.0, "trailingAnnualDividendRate": 0.0, "symbol": "6838.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 57, Fuxing North Road", "address2": "8F-6 Songshan District", "city": "Taipei", "zip": "105", "country": "Taiwan", "phone": "886 2 2755 7659", "fax": "886 2 2755 3023", "website": "https://www.formosapharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Formosa Pharmaceuticals, Inc., a late-preclinical and early clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing APP13007, an aqueous-based ophthalmic nanosuspension that is in Phase III clinical trial for the treatment of post-operative pain and inflammatory eye conditions; TSY-0110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resistant infections. The company also develops APP13002, a topical antibiotic for infectious eye diseases, such as blepharitis; and MPT0E028, a novel pan- histone deacetylase inhibitor for solid tumors, such as hepatomas and colorectal cancer, as well as lung fibrosis. It has a collaboration agreement with Eyenovia, Inc. for the development of novel ophthalmic therapeutic. The company was founded in 2010 and is headquartered in Taipei City, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Erick  Co Ph.D.", "title": "Pres & CEO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hsi-Chung  Tsao", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}